News

Mifepristone can continue to be mailed to patients without an in-person visit with a doctor after the US Supreme Court rejected a lawsuit that challenged regulation of the abortion pill ...
The abortion pill mifepristone will remain on the market for now -- but come Saturday morning, access will be severely restricted while the Biden administration asks the Supreme Court to intervene ...
Mifepristone, a drug used in medication abortion, faces tighter restrictions than it has in years after a federal appeals court ordered a return to the rules that were put in place when the drug ...
Mifepristone is the first of a two-drug regimen that has long been the standard for medication abortion in the US since it was approved by the FDA in 2000.
The Supreme Court on Tuesday will weigh whether to limit access to mifepristone, one of the country’s most widely used abortion drugs. The case was brought by antiabortion groups seeking to ...
The abortion pill mifepristone will remain available in the U.S., for now. NPR's Adrian Florido talks to Julie Rovner of KFF Health News.
A package of mifepristone abortion pills is shown on the left shortly after the drug was approved by the FDA in 2000, while a Viagra pill and packaging are pictured on the right in 1999.
The legal battle over mifepristone, one of two medications used to provide abortions and treat miscarriages, continued Wednesday when a federal appeals court heard arguments about access to the drug.
It did not ‘save’ mifepristone. Its ruling on mifepristone is nothing to celebrate. June 17, 2024. 5 min. Packets of Mifepristone, a pill used in medication abortions, at a New Mexico clinic ...
Mifepristone and Plan B both involve reproductive health, but one is intended to end a pregnancy while the second stops pregnancy from happening. Trump presses Israel as ceasefire deal with Iran ...
Supreme Court tosses out conservative Christian group’s attack on the abortion pill mifepristone, the most common method of abortion in the U.S. June 13, 2024 ...
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.